Published in Clin Exp Allergy on December 01, 2001
CD43 interacts with moesin and ezrin and regulates its redistribution to the uropods of T lymphocytes at the cell-cell contacts. Blood (1998) 1.91
Moesin interacts with the cytoplasmic region of intercellular adhesion molecule-3 and is redistributed to the uropod of T lymphocytes during cell polarization. J Cell Biol (1997) 1.84
Targeting of non-Ig sequences in place of the V segment by somatic hypermutation. Nature (1995) 1.80
Correlation of fluconazole MICs with clinical outcome in cryptococcal infection. Antimicrob Agents Chemother (2000) 1.51
Serotype-specific pneumococcal disease may be influenced by mannose-binding lectin deficiency. Eur Respir J (2010) 1.50
Polarization and interaction of adhesion molecules P-selectin glycoprotein ligand 1 and intercellular adhesion molecule 3 with moesin and ezrin in myeloid cells. Blood (2000) 1.35
Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients. HIV Clin Trials (2003) 1.18
CD43 monoclonal antibodies recognize the large sialoglycoprotein of human leukocytes. Eur J Immunol (1987) 1.12
Influence of variants of Fc gamma receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor alpha therapy in rheumatoid arthritis. Ann Rheum Dis (2008) 1.05
Intracellular events involved in CD5-induced human T cell activation and proliferation. J Immunol (1992) 1.03
Concentrations of cefmetazole in plasma and tissue resulting from peri-incisional administration before appendectomy. Antimicrob Agents Chemother (1984) 1.02
Outbreak of Brucella melitensis among microbiology laboratory workers. J Clin Microbiol (1994) 0.95
Transient immunologic defect in a case of Listeria rhombencephalitis. Arch Neurol (1987) 0.95
Impaired recovery of CD4+ cell counts following highly active antiretroviral therapy in drug-naïve patients coinfected with human immunodeficiency virus and hepatitis C virus. Eur J Clin Microbiol Infect Dis (2003) 0.93
Fatal Psychrobacter immobilis infection in a patient with AIDS. AIDS (1994) 0.92
Liver toxicity of antiretroviral combinations including atazanavir/ritonavir in patients co-infected with HIV and hepatitis viruses: impact of pre-existing liver fibrosis. J Antimicrob Chemother (2008) 0.92
Interaction of recombinant and natural soluble CD5 forms with an alternative cell surface ligand. Eur J Immunol (1999) 0.92
Expression of the innate defense receptor S5D-SRCRB in the urogenital tract. Tissue Antigens (2014) 0.92
Biochemical characterization of recombinant and circulating human Spalpha. Tissue Antigens (2004) 0.91
Human CD5 signaling and constitutive phosphorylation of C-terminal serine residues by casein kinase II. J Immunol (1998) 0.90
Leptospira abortion in horses. J Vet Diagn Invest (1989) 0.90
Induction of interleukin 2 (IL 2) and interferon-gamma and enhancement of IL 2 receptor expression by a CD26 monoclonal antibody. Eur J Immunol (1991) 0.88
Subacute cutaneous lupus erythematosus: clinicopathologic findings in thirteen cases. J Am Acad Dermatol (1988) 0.88
Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients. J Viral Hepat (2006) 0.86
High prevalence of genetically-determined mannose binding lectin deficiency in young children with invasive pneumococcal disease. Clin Microbiol Infect (2014) 0.86
Stimulation through the TCR/CD3 complex up-regulates the CD2 surface expression on human T lymphocytes. J Immunol (1991) 0.86
Association of mannose-binding lectin gene polymorphisms with antiphospholipid syndrome, cardiovascular disease and chronic damage in patients with systemic lupus erythematosus. Rheumatology (Oxford) (2006) 0.86
Cervical lipomatosis in HIV-infected patients: a case-control study. HIV Med (2007) 0.85
The cytoplasmic domain of CD5 mediates both TCR/CD3-dependent and -independent diacylglycerol production. J Immunol (1997) 0.85
Association of an activation inducible serine kinase activity with CD5. J Immunol (1993) 0.84
High circulating levels of soluble scavenger receptors (sCD5 and sCD6) in patients with primary Sjögren's syndrome. Rheumatology (Oxford) (2001) 0.84
Role of two conserved cytoplasmic threonine residues (T410 and T412) in CD5 signaling. J Immunol (2001) 0.83
Peripheral endothelial progenitor cells (CD133 +) for therapeutic vasculogenesis in a patient with critical limb ischemia. One year follow-up. Cytotherapy (2007) 0.83
Impaired post-transcriptional expression of interleukin-2 receptor in pokeweed mitogen-activated T cells. Eur J Immunol (1992) 0.83
Residues Y429 and Y463 of the human CD5 are targeted by protein tyrosine kinases. Eur J Immunol (2001) 0.83
Identification of a natural soluble form of human CD5. Tissue Antigens (1999) 0.83
Relationship between osteopenia, free testosterone, and vitamin D metabolite levels in HIV-infected patients with and without highly active antiretroviral therapy. AIDS Res Hum Retroviruses (2005) 0.83
The relationship between antiretroviral prescription patterns and treatment guidelines in treatment-naïve HIV-1-infected patients. HIV Med (2009) 0.82
Conformation of the hypervariable region L3 without the key proline residue. Protein Sci (1996) 0.82
[Electromagnetic interference between automatic defibrillators and digital and analog cellular telephones]. Rev Esp Cardiol (1998) 0.82
A reporter gene to analyse the hypermutation of immunoglobulin genes. J Mol Biol (1995) 0.82
Genomic organization of the human CD5 gene. Immunogenetics (2000) 0.81
Effectiveness and safety of simplification from tenofovir-lamivudine (TDF-3TC) to tenofovir-emtricitabine (TDF-FTC) co-formulation (Truvada) in virologically suppressed HIV-infected patients on HAART. Eur J Clin Microbiol Infect Dis (2008) 0.81
Signaling through CD5 involves acidic sphingomyelinase, protein kinase C-zeta, mitogen-activated protein kinase kinase, and c-Jun NH2-terminal kinase. J Immunol (1999) 0.81
Influence of mannose-binding lectin gene polymorphisms on the invasiveness of cytomegalovirus disease after solid organ transplantation. Transplant Proc (2009) 0.80
Traumatic aorto-esophageal fistula. J Thorac Cardiovasc Surg (1984) 0.80
[P. falciparum and P. malariae malaria complicated by pulmonary edema with disseminated intravascular coagulation]. Presse Med (1983) 0.80
Genetic and structural analysis of MBL2 and MASP2 polymorphisms in south-eastern African children. Tissue Antigens (2009) 0.80
Images in cardiovascular medicine. Uterine intravenous leiomyomatosis extending through the inferior vena cava into the right cardiac cavities. Circulation (2000) 0.80
Malacoplakia of the pelvis. Report of a case with cytologic and ultrastructural findings obtained by fine needle aspiration. Acta Cytol (1992) 0.79
Mannose-binding lectin-low genotypes are associated with milder systemic and immunological disease expression in primary Sjögren's syndrome. Rheumatology (Oxford) (2009) 0.79
Chronic dilatative myocarditis caused by Trypanosoma cruzi in two dogs. J Am Vet Med Assoc (1989) 0.79
A comparison of three different prophylactic parenteral antibiotic regimens in colorectal surgery: a prospective study. Int Surg (1986) 0.79
Involvement of the CDw50 molecule in allorecognition. Tissue Antigens (1990) 0.79
Simplicity and efficacy of a once-daily antiretroviral regimen with didanosine, lamivudine, and efavirenz in naïve patients: the VESD study. HIV Clin Trials (2006) 0.78
Desialylation of T lymphocytes overcomes the monocyte dependency of pokeweed mitogen-induced T-cell activation. Immunology (1997) 0.78
Bladder cancer in Spain 2011: population based study. J Urol (2013) 0.78
Identification of a new HLA-DRB1 allele (DRB1*0318) in three members of a Caucasian Spanish family. Tissue Antigens (2001) 0.77
Primary hepatic actinomycosis presenting as purulent pericarditis with cardiac tamponade. Infection (2011) 0.77
Systemic prophylaxis with gentamicin-metronidazole in appendicectomy and colorectal surgery: a prospective controlled clinical study. Int Surg (1984) 0.77
Differential effects of anti-CD45 monoclonal antibody on human B cell proliferation: a monoclonal antibody recognizing a neuraminidase-sensitive epitope of the T200 molecule enhances anti-immunoglobulin-induced proliferation. Eur J Immunol (1990) 0.77
[77 year old man with jaundice and pruritus]. Rev Clin Esp (2006) 0.77
Evolutionarily conserved transcription regulatory elements within the 5'-flanking region of the human CD5 gene. Tissue Antigens (1996) 0.77
Interleukin-4 receptor alpha polymorphisms in primary Sjögren's syndrome. Clin Exp Rheumatol (2004) 0.76
Relevance of individual CD5 extracellular domains on antibody recognition, glycosylation and co-mitogenic signalling. Tissue Antigens (1999) 0.76
Persistent low C3 levels associated with meningococcal meningitis and membranoproliferative glomerulonephritis. Am J Nephrol (1990) 0.76
[Hepatic lesion caused by acetaminophen. Apropos of a case with unusual portal involvement]. Rev Clin Esp (1983) 0.75
[Campylobacter bacteremia and HIV infection]. Enferm Infecc Microbiol Clin (1992) 0.75
[Prolonged fever and Mycoplasma pneumoniae infection]. Enferm Infecc Microbiol Clin (1994) 0.75
Discrepancies between serology- and sequence-based typing of HLA class I alleles among unrelated donor/recipient pairs. Transplant Proc (1999) 0.75
Life-threatening Pseudomonas aeruginosa infections in patients with infection due to human immunodeficiency virus. Clin Infect Dis (1992) 0.75
[Mycobacterium scrofulaceum and AIDS]. Enferm Infecc Microbiol Clin (1996) 0.75
[Tuberculous splenic abscesses in AIDS]. Enferm Infecc Microbiol Clin (1995) 0.75
The protein kinase C-independent human B cell proliferation induced via surface immunoglobulins is unaffected by CD45 monoclonal antibodies. Immunobiology (1991) 0.75
[Diffuse hyperplasia of Brunner's glands in relation to pancreatic and/or renal disease]. Med Clin (Barc) (1983) 0.75
[Severe infections in parenteral drug addicts]. Enferm Infecc Microbiol Clin (1989) 0.75
[Deficiency of intestinal lactase activity in chronic alcoholics]. Rev Clin Esp (1975) 0.75
[Dysphagia as the sole manifestation of Arnold-Chiari malformation in adults]. Neurologia (1991) 0.75
[Uncommon complications of retroperitoneal cysts]. Actas Urol Esp (1977) 0.75
[Mixed retroperitoneal liposarcoma. Comments on the use of computerized axial tomography]. Rev Esp Enferm Apar Dig (1978) 0.75
[Ultrasonography and impedance plethysmography versus phlebography in the diagnosis of deep venous thrombosis]. Angiologia (1985) 0.75
[Anti-nuclear envelope antibodies associated with Sjogren's syndrome and non-Hodgkin's lymphoma]. Med Clin (Barc) (1990) 0.75
[Prevalence of serum markers of hepatitis B virus in medical and non-medical personnel in a general hospital]. Med Clin (Barc) (1984) 0.75
[Cost-benefit analysis of a program for vaccination against hepatitis B in health personnel of a hospital]. Med Clin (Barc) (1984) 0.75
[Diagnosis of renal angiomyolipoma by means of computerized axial tomography]. Actas Urol Esp (1979) 0.75
[Leukocytoclastic vasculitis: analysis of 62 cases]. Med Clin (Barc) (1987) 0.75
[Painful ophthalmoplegia associated with infectious mononucleosis]. Neurologia (1992) 0.75
[Venous localization, dissection and cannulation facilitated by ultrasound]. Angiologia (1987) 0.75
[Incidence of chronic hepatitis in alcoholic patients]. Rev Clin Esp (1983) 0.75
[Hepatitis caused by diphenylhydantoin]. Med Clin (Barc) (1984) 0.75
[Pseudothrombophlebitis: a seldom described entity]. Med Clin (Barc) (1987) 0.75
Non-invasive diagnosis of D.V.T. false positive due to hydatid disease. Eur J Vasc Surg (1987) 0.75
Phenol lumbar sympathectomy in severe arterial disease of the lower limbs: a hemodynamic study. Int Surg (1983) 0.75
Effects of substitutive triiodothyronine therapy on intracellular nucleotide levels in donor organs. Transplant Proc (1991) 0.75
[Infections by Candida and cryptococci]. Enferm Infecc Microbiol Clin (1998) 0.75
Possible estrogen-induced NMS. DICP (1989) 0.75
[Hemorrhagic complications of anticoagulants (heparin and dicoumarins) in the treatment of deep venous thrombosis. Report of 176 consecutive patients]. Angiologia (1984) 0.75
Laboratory control of continuous intravenous heparin therapy with Howel time and activated partial thromboplastin time. A prospective, randomized and blind study. Angiology (1985) 0.75
Tuberculous splenic abscesses in patients with the acquired immune deficiency syndrome. Tubercle (1991) 0.75